EUVIMEDEUVIMED entdecken
Crossref

Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis

Robert M Genta, Kevin O Turner, Cristian Robiou, Anuradha Singhal, Massimo Rugge

Digestive Diseases · 2023

DOI: 10.1159/000527479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases, 2023. Verfasst von Robert M Genta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inform Diagnostics, Irving, Texas, USA. Hauptthemen laut MEDLINE: Gastritis, Gastritis, Atrophic, Stomach Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 21-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Incomplete intestinal metaplasia (IM) is reportedly associated with higher gastric cancer (GC) risk than its complete variant. AGA Guidelines recommend including IM subtyping in routine pathology reports. This study assesses the prevalence of complete versus incomplete IM in gastric conditions with different GC risks.

Methods

IM subtyping (complete vs. incomplete) and grading (IM extension: G1: ≤30%; G2: >30%) were assessed in 386 patients with IM + ve gastric biopsy sets that included both antral and oxyntic samples. Cases were categorized as: (a) IM foci in otherwise normal mucosa (n = 59); (b) Helicobacter pylori gastritis (n = 138); (c) reactive gastropathy (141); and (d) autoimmune atrophic gastritis (AIG, n = 48). Odds ratios (OR) and their 95% CI were used in comparing the prevalence of incomplete IM and the correlation between subtype and IM extension.

Results

Incomplete IM was present in 37.7% of patients with H. pylori gastritis, 8.3% of those with AIG 5.0% of those with reactive gastropathy, and none of those with otherwise normal mucosa. Incomplete IM was strongly associated with more extensive (G2-IM) mucosal intestinalization (OR = 6.69; 95% CI = 2.77–9.40).

Conclusion

Incomplete IM is significantly more prevalent in conditions (H. pylori gastritis) known to carry a higher risk of GC and is strongly associated with its extension. The low prevalence of incomplete IM in AIG (8.3%) and reactive gastropathy (5.2%) is in keeping with the low GC risk associated with these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GastritisGastritis, AtrophicStomach NeoplasmsPrecancerous ConditionsHelicobacter InfectionsHelicobacter pyloriHumansGastric MucosaMetaplasia

Stichwörter der Autor:innen

Autoimmune atrophic gastritisGastric cancerHelicobacter pylori gastritisIncomplete intestinal metaplasiaIntestinal metaplasia

Autor:innen und Institutionen

  • Inform Diagnostics, Irving, Texas, USA.
  • Departments of Pathology and Medicine (Gastroenterology), Baylor College of Medicine, Houston, Texas, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Medicine-DIMED - Surgical Pathology and Cytopathology, University di Padova, Padova, Italy.

Zitieren

APA

Genta, R. M., Turner, K. O., Robiou, C., Singhal, A., & Rugge, M. (2023). Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis. Digestive Diseases. https://doi.org/10.1159/000527479

Vancouver

Genta RM, Turner KO, Robiou C, Singhal A, Rugge M. Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis. Digestive Diseases. 2023. doi:10.1159/000527479

BibTeX
@article{Genta2023,
  author = {Genta, Robert M and Turner, Kevin O and Robiou, Cristian and Singhal, Anuradha and Rugge, Massimo},
  title = {Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis},
  journal = {Digestive Diseases},
  year = {2023},
  doi = {10.1159/000527479}
}
Kostenlos starten →